UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043336
Receipt number R000049412
Scientific Title Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in laparoscopic gynecological surgery - Comparison with the oblique subcostal transversus abdominis plane block : a pilot randomized controlled trial
Date of disclosure of the study information 2021/03/01
Last modified on 2024/01/29 11:43:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in laparoscopic gynecological surgery - Comparison with the oblique subcostal transversus abdominis plane block : a pilot randomized controlled trial

Acronym

Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in laparoscopic gynecological surgery - Comparison with the oblique subcostal transversus abdominis plane block : a pilot randomized controlled trial

Scientific Title

Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in laparoscopic gynecological surgery - Comparison with the oblique subcostal transversus abdominis plane block : a pilot randomized controlled trial

Scientific Title:Acronym

Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in laparoscopic gynecological surgery - Comparison with the oblique subcostal transversus abdominis plane block : a pilot randomized controlled trial

Region

Japan


Condition

Condition

Gynecologic diseases such as uterine malignancies, uterine fibroids, and adenomyosis

Classification by specialty

Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The blockage of thoracoabdominal nerves through perichondrial approach (TAPA) is a recently described novel regional anesthesia method which potentially provides effective and extensive sensorial block of the thoracoabdominal region. The analgesic effect of M-TAPA in laparoscopic gynecological surgery and the transition of blood concentration of local anesthetics are compared with the oblique subcostal transversus abdominis plane block.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Quality Recovery 15 (QoR-15) score at the day before surgery and 48 hours after surgery

Key secondary outcomes

Numerical rating scale (NRS) at 2/12/24/48 hours after surgery
Measurement of blood concentration of levobupivacaine at 15/30/45/60/120 minutes after block enforcement
Time to request the first bolus on the patient controlled analgesia after surgery
Frequency of non-opioid analgesic use
Occurrence of postoperative nausea and vomiting


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

modified thoracoabdominal nerves block through perichondrial approach

Interventions/Control_2

oblique subcostal transverse abdominis plane block

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

Patients scheduled laparoscopic hysterectomy at Nara Medical University Hospital

Key exclusion criteria

Rejection
Communication difficulty
Chronic opioid use (Daily use or usage morphine equivalent more than 60mg per day within 1 month before surgery)
Skin disease at puncture site
Allergy to local anesthetics
Coagulation disorder
Patients who have received antithrombotic therapy and conflict with a sufficient period of drug withdrawal according to the guideline published by JSA/JSRA/JSPC
Body weight < 42 kg
BMI > 35
Visit restrictions due to prevention for COVID-19
Judged inappropriate by the investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takanori
Middle name
Last name Suzuka

Organization

Nara Medical University

Division name

Department of Anesthesiology

Zip code

634-8522

Address

840 Shijyo-cho, Kashihara, Nara

TEL

0744-22-3051

Email

szk.tknr.0825@naramed-u.ac.jp


Public contact

Name of contact person

1st name Takanori
Middle name
Last name Suzuka

Organization

Nara Medical University

Division name

Department of Anesthesiology

Zip code

634-8522

Address

840 Shijyo-cho, Kashihara, Nara

TEL

0744-22-3051

Homepage URL


Email

szk.tknr.0825@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University

Address

840 Shijyo-cho, Kashihara, Nara

Tel

0744-22-3051

Email

ino_rinri@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol

https://doi.org/10.3390/jcm13030712

Publication of results

Published


Result

URL related to results and publications

https://center6.umin.ac.jp/cgi-bin/ctr/ctr_up_reg_f5.cgi

Number of participants that the trial has enrolled

46

Results

The primary outcome was changes in QoR-15 scores on postoperative days (POD) 1 and 2 from the preoperative baseline. Group differences (M-TAPA- OSTAPB) in mean changes from baseline in QoR-15 scores on POD 1 and 2 were -11.3 (95% confidence interval (CI), -24.9 to 2.4, standard deviation (SD), 22.8) and -7.0 (95% CI, -20.5 to 6.6, SD, 18.7), respectively.

Results date posted

2024 Year 01 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Female patients aged 20-75 years with an American Society of Anesthesiologists physical status of 1-2 who were scheduled for TLH with four abdominal ports were enrolled in this study.

Participant flow

Three months after the surgery, the electronic medical record was used to check the patient's condition and to check for adverse events.

Adverse events

Nothing

Outcome measures

The primary outcome was the changes in the QoR-15 scores on POD 1 and 2 from the preoperative baseline, calculating the group differences and SDs between M-TAPA and OSTAPB. The QoR-15 questionnaire is recommended for assessing postoperative patient comfort and pain in perioperative clinical trials. It consists of five domains related to quality of care: pain, physical comfort, physical independence, psychological support, and emotional state. The questionnaire used an 11-point NRS, with scores ranging from 0 (extremely poor recovery) to 150 (excellent recovery).
The secondary outcomes were resting and dynamic pain scores (NRS, 0-10) at 2 h after surgery, POD 1, and POD 2; the PClevo 15, 30, 45, 60, and 120 min after the initial intraoperative levobupivacaine bolus injection; comparison of the peak plasma concentration (Cmax) and time to peak plasma concentration (Tmax) for levobupivacaine; procedure duration (from skin preparation to nerve block completion); and postoperative fentanyl consumption. The Cmax and Tmax values of levobupivacaine were directly recorded for each patient based on the measured values.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 02 Month 05 Day

Date of IRB

2021 Year 03 Month 01 Day

Anticipated trial start date

2021 Year 03 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 02 Month 16 Day

Last modified on

2024 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049412


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name